[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Treatment and Prevention of Herpes Labialis Market Growth (Status and Outlook) 2023-2029

March 2023 | 111 pages | ID: GE9DE71E4FFAEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Treatment and Prevention of Herpes Labialis Industry Forecast” looks at past sales and reviews total world Treatment and Prevention of Herpes Labialis sales in 2022, providing a comprehensive analysis by region and market sector of projected Treatment and Prevention of Herpes Labialis sales for 2023 through 2029. With Treatment and Prevention of Herpes Labialis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Treatment and Prevention of Herpes Labialis industry.

This Insight Report provides a comprehensive analysis of the global Treatment and Prevention of Herpes Labialis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Treatment and Prevention of Herpes Labialis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Treatment and Prevention of Herpes Labialis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Treatment and Prevention of Herpes Labialis and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Treatment and Prevention of Herpes Labialis.

The global Treatment and Prevention of Herpes Labialis market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Treatment and Prevention of Herpes Labialis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Treatment and Prevention of Herpes Labialis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Treatment and Prevention of Herpes Labialis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Treatment and Prevention of Herpes Labialis players cover GSK, Novartis, Teva, Mylan, Cadila, Apotex, Daewoong Pharmaceutical, Livzon and Luoxin, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Treatment and Prevention of Herpes Labialis market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Valacyclovir
  • Aciclovir
  • Famciclovir
  • Docosanol
  • Other
Segmentation by application
  • External Use
  • Oral
  • Injection
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • GSK
  • Novartis
  • Teva
  • Mylan
  • Cadila
  • Apotex
  • Daewoong Pharmaceutical
  • Livzon
  • Luoxin
  • Med shine
  • Bayer(Campho Phenique)
  • Blistex
  • Kelun Group
  • Hikma
  • Haiwang
  • Carmex
  • Cipher
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Treatment and Prevention of Herpes Labialis Market Size 2018-2029
  2.1.2 Treatment and Prevention of Herpes Labialis Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Treatment and Prevention of Herpes Labialis Segment by Type
  2.2.1 Valacyclovir
  2.2.2 Aciclovir
  2.2.3 Famciclovir
  2.2.4 Docosanol
  2.2.5 Other
2.3 Treatment and Prevention of Herpes Labialis Market Size by Type
  2.3.1 Treatment and Prevention of Herpes Labialis Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Treatment and Prevention of Herpes Labialis Market Size Market Share by Type (2018-2023)
2.4 Treatment and Prevention of Herpes Labialis Segment by Application
  2.4.1 External Use
  2.4.2 Oral
  2.4.3 Injection
2.5 Treatment and Prevention of Herpes Labialis Market Size by Application
  2.5.1 Treatment and Prevention of Herpes Labialis Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Treatment and Prevention of Herpes Labialis Market Size Market Share by Application (2018-2023)

3 TREATMENT AND PREVENTION OF HERPES LABIALIS MARKET SIZE BY PLAYER

3.1 Treatment and Prevention of Herpes Labialis Market Size Market Share by Players
  3.1.1 Global Treatment and Prevention of Herpes Labialis Revenue by Players (2018-2023)
  3.1.2 Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Players (2018-2023)
3.2 Global Treatment and Prevention of Herpes Labialis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 TREATMENT AND PREVENTION OF HERPES LABIALIS BY REGIONS

4.1 Treatment and Prevention of Herpes Labialis Market Size by Regions (2018-2023)
4.2 Americas Treatment and Prevention of Herpes Labialis Market Size Growth (2018-2023)
4.3 APAC Treatment and Prevention of Herpes Labialis Market Size Growth (2018-2023)
4.4 Europe Treatment and Prevention of Herpes Labialis Market Size Growth (2018-2023)
4.5 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Treatment and Prevention of Herpes Labialis Market Size by Country (2018-2023)
5.2 Americas Treatment and Prevention of Herpes Labialis Market Size by Type (2018-2023)
5.3 Americas Treatment and Prevention of Herpes Labialis Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Treatment and Prevention of Herpes Labialis Market Size by Region (2018-2023)
6.2 APAC Treatment and Prevention of Herpes Labialis Market Size by Type (2018-2023)
6.3 APAC Treatment and Prevention of Herpes Labialis Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Treatment and Prevention of Herpes Labialis by Country (2018-2023)
7.2 Europe Treatment and Prevention of Herpes Labialis Market Size by Type (2018-2023)
7.3 Europe Treatment and Prevention of Herpes Labialis Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Treatment and Prevention of Herpes Labialis by Region (2018-2023)
8.2 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Type (2018-2023)
8.3 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL TREATMENT AND PREVENTION OF HERPES LABIALIS MARKET FORECAST

10.1 Global Treatment and Prevention of Herpes Labialis Forecast by Regions (2024-2029)
  10.1.1 Global Treatment and Prevention of Herpes Labialis Forecast by Regions (2024-2029)
  10.1.2 Americas Treatment and Prevention of Herpes Labialis Forecast
  10.1.3 APAC Treatment and Prevention of Herpes Labialis Forecast
  10.1.4 Europe Treatment and Prevention of Herpes Labialis Forecast
  10.1.5 Middle East & Africa Treatment and Prevention of Herpes Labialis Forecast
10.2 Americas Treatment and Prevention of Herpes Labialis Forecast by Country (2024-2029)
  10.2.1 United States Treatment and Prevention of Herpes Labialis Market Forecast
  10.2.2 Canada Treatment and Prevention of Herpes Labialis Market Forecast
  10.2.3 Mexico Treatment and Prevention of Herpes Labialis Market Forecast
  10.2.4 Brazil Treatment and Prevention of Herpes Labialis Market Forecast
10.3 APAC Treatment and Prevention of Herpes Labialis Forecast by Region (2024-2029)
  10.3.1 China Treatment and Prevention of Herpes Labialis Market Forecast
  10.3.2 Japan Treatment and Prevention of Herpes Labialis Market Forecast
  10.3.3 Korea Treatment and Prevention of Herpes Labialis Market Forecast
  10.3.4 Southeast Asia Treatment and Prevention of Herpes Labialis Market Forecast
  10.3.5 India Treatment and Prevention of Herpes Labialis Market Forecast
  10.3.6 Australia Treatment and Prevention of Herpes Labialis Market Forecast
10.4 Europe Treatment and Prevention of Herpes Labialis Forecast by Country (2024-2029)
  10.4.1 Germany Treatment and Prevention of Herpes Labialis Market Forecast
  10.4.2 France Treatment and Prevention of Herpes Labialis Market Forecast
  10.4.3 UK Treatment and Prevention of Herpes Labialis Market Forecast
  10.4.4 Italy Treatment and Prevention of Herpes Labialis Market Forecast
  10.4.5 Russia Treatment and Prevention of Herpes Labialis Market Forecast
10.5 Middle East & Africa Treatment and Prevention of Herpes Labialis Forecast by Region (2024-2029)
  10.5.1 Egypt Treatment and Prevention of Herpes Labialis Market Forecast
  10.5.2 South Africa Treatment and Prevention of Herpes Labialis Market Forecast
  10.5.3 Israel Treatment and Prevention of Herpes Labialis Market Forecast
  10.5.4 Turkey Treatment and Prevention of Herpes Labialis Market Forecast
  10.5.5 GCC Countries Treatment and Prevention of Herpes Labialis Market Forecast
10.6 Global Treatment and Prevention of Herpes Labialis Forecast by Type (2024-2029)
10.7 Global Treatment and Prevention of Herpes Labialis Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 GSK
  11.1.1 GSK Company Information
  11.1.2 GSK Treatment and Prevention of Herpes Labialis Product Offered
  11.1.3 GSK Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 GSK Main Business Overview
  11.1.5 GSK Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis Treatment and Prevention of Herpes Labialis Product Offered
  11.2.3 Novartis Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 Teva
  11.3.1 Teva Company Information
  11.3.2 Teva Treatment and Prevention of Herpes Labialis Product Offered
  11.3.3 Teva Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Teva Main Business Overview
  11.3.5 Teva Latest Developments
11.4 Mylan
  11.4.1 Mylan Company Information
  11.4.2 Mylan Treatment and Prevention of Herpes Labialis Product Offered
  11.4.3 Mylan Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Mylan Main Business Overview
  11.4.5 Mylan Latest Developments
11.5 Cadila
  11.5.1 Cadila Company Information
  11.5.2 Cadila Treatment and Prevention of Herpes Labialis Product Offered
  11.5.3 Cadila Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Cadila Main Business Overview
  11.5.5 Cadila Latest Developments
11.6 Apotex
  11.6.1 Apotex Company Information
  11.6.2 Apotex Treatment and Prevention of Herpes Labialis Product Offered
  11.6.3 Apotex Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Apotex Main Business Overview
  11.6.5 Apotex Latest Developments
11.7 Daewoong Pharmaceutical
  11.7.1 Daewoong Pharmaceutical Company Information
  11.7.2 Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Product Offered
  11.7.3 Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Daewoong Pharmaceutical Main Business Overview
  11.7.5 Daewoong Pharmaceutical Latest Developments
11.8 Livzon
  11.8.1 Livzon Company Information
  11.8.2 Livzon Treatment and Prevention of Herpes Labialis Product Offered
  11.8.3 Livzon Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Livzon Main Business Overview
  11.8.5 Livzon Latest Developments
11.9 Luoxin
  11.9.1 Luoxin Company Information
  11.9.2 Luoxin Treatment and Prevention of Herpes Labialis Product Offered
  11.9.3 Luoxin Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Luoxin Main Business Overview
  11.9.5 Luoxin Latest Developments
11.10 Med shine
  11.10.1 Med shine Company Information
  11.10.2 Med shine Treatment and Prevention of Herpes Labialis Product Offered
  11.10.3 Med shine Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Med shine Main Business Overview
  11.10.5 Med shine Latest Developments
11.11 Bayer(Campho Phenique)
  11.11.1 Bayer(Campho Phenique) Company Information
  11.11.2 Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Product Offered
  11.11.3 Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Bayer(Campho Phenique) Main Business Overview
  11.11.5 Bayer(Campho Phenique) Latest Developments
11.12 Blistex
  11.12.1 Blistex Company Information
  11.12.2 Blistex Treatment and Prevention of Herpes Labialis Product Offered
  11.12.3 Blistex Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 Blistex Main Business Overview
  11.12.5 Blistex Latest Developments
11.13 Kelun Group
  11.13.1 Kelun Group Company Information
  11.13.2 Kelun Group Treatment and Prevention of Herpes Labialis Product Offered
  11.13.3 Kelun Group Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 Kelun Group Main Business Overview
  11.13.5 Kelun Group Latest Developments
11.14 Hikma
  11.14.1 Hikma Company Information
  11.14.2 Hikma Treatment and Prevention of Herpes Labialis Product Offered
  11.14.3 Hikma Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.14.4 Hikma Main Business Overview
  11.14.5 Hikma Latest Developments
11.15 Haiwang
  11.15.1 Haiwang Company Information
  11.15.2 Haiwang Treatment and Prevention of Herpes Labialis Product Offered
  11.15.3 Haiwang Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.15.4 Haiwang Main Business Overview
  11.15.5 Haiwang Latest Developments
11.16 Carmex
  11.16.1 Carmex Company Information
  11.16.2 Carmex Treatment and Prevention of Herpes Labialis Product Offered
  11.16.3 Carmex Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.16.4 Carmex Main Business Overview
  11.16.5 Carmex Latest Developments
11.17 Cipher
  11.17.1 Cipher Company Information
  11.17.2 Cipher Treatment and Prevention of Herpes Labialis Product Offered
  11.17.3 Cipher Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2018-2023)
  11.17.4 Cipher Main Business Overview
  11.17.5 Cipher Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Treatment and Prevention of Herpes Labialis Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Valacyclovir
Table 3. Major Players of Aciclovir
Table 4. Major Players of Famciclovir
Table 5. Major Players of Docosanol
Table 6. Major Players of Other
Table 7. Treatment and Prevention of Herpes Labialis Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Treatment and Prevention of Herpes Labialis Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Treatment and Prevention of Herpes Labialis Market Size Market Share by Type (2018-2023)
Table 10. Treatment and Prevention of Herpes Labialis Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Treatment and Prevention of Herpes Labialis Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Treatment and Prevention of Herpes Labialis Market Size Market Share by Application (2018-2023)
Table 13. Global Treatment and Prevention of Herpes Labialis Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Player (2018-2023)
Table 15. Treatment and Prevention of Herpes Labialis Key Players Head office and Products Offered
Table 16. Treatment and Prevention of Herpes Labialis Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Treatment and Prevention of Herpes Labialis Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Treatment and Prevention of Herpes Labialis Market Size Market Share by Regions (2018-2023)
Table 21. Global Treatment and Prevention of Herpes Labialis Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Treatment and Prevention of Herpes Labialis Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Treatment and Prevention of Herpes Labialis Market Size Market Share by Country (2018-2023)
Table 25. Americas Treatment and Prevention of Herpes Labialis Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Treatment and Prevention of Herpes Labialis Market Size Market Share by Type (2018-2023)
Table 27. Americas Treatment and Prevention of Herpes Labialis Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Treatment and Prevention of Herpes Labialis Market Size Market Share by Application (2018-2023)
Table 29. APAC Treatment and Prevention of Herpes Labialis Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Treatment and Prevention of Herpes Labialis Market Size Market Share by Region (2018-2023)
Table 31. APAC Treatment and Prevention of Herpes Labialis Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Treatment and Prevention of Herpes Labialis Market Size Market Share by Type (2018-2023)
Table 33. APAC Treatment and Prevention of Herpes Labialis Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Treatment and Prevention of Herpes Labialis Market Size Market Share by Application (2018-2023)
Table 35. Europe Treatment and Prevention of Herpes Labialis Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Treatment and Prevention of Herpes Labialis Market Size Market Share by Country (2018-2023)
Table 37. Europe Treatment and Prevention of Herpes Labialis Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Treatment and Prevention of Herpes Labialis Market Size Market Share by Type (2018-2023)
Table 39. Europe Treatment and Prevention of Herpes Labialis Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Treatment and Prevention of Herpes Labialis Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Treatment and Prevention of Herpes Labialis
Table 48. Key Market Challenges & Risks of Treatment and Prevention of Herpes Labialis
Table 49. Key Industry Trends of Treatment and Prevention of Herpes Labialis
Table 50. Global Treatment and Prevention of Herpes Labialis Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Treatment and Prevention of Herpes Labialis Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Treatment and Prevention of Herpes Labialis Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Treatment and Prevention of Herpes Labialis Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. GSK Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 55. GSK Treatment and Prevention of Herpes Labialis Product Offered
Table 56. GSK Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. GSK Main Business
Table 58. GSK Latest Developments
Table 59. Novartis Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 60. Novartis Treatment and Prevention of Herpes Labialis Product Offered
Table 61. Novartis Main Business
Table 62. Novartis Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Novartis Latest Developments
Table 64. Teva Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 65. Teva Treatment and Prevention of Herpes Labialis Product Offered
Table 66. Teva Main Business
Table 67. Teva Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Teva Latest Developments
Table 69. Mylan Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 70. Mylan Treatment and Prevention of Herpes Labialis Product Offered
Table 71. Mylan Main Business
Table 72. Mylan Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Mylan Latest Developments
Table 74. Cadila Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 75. Cadila Treatment and Prevention of Herpes Labialis Product Offered
Table 76. Cadila Main Business
Table 77. Cadila Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Cadila Latest Developments
Table 79. Apotex Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 80. Apotex Treatment and Prevention of Herpes Labialis Product Offered
Table 81. Apotex Main Business
Table 82. Apotex Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Apotex Latest Developments
Table 84. Daewoong Pharmaceutical Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 85. Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Product Offered
Table 86. Daewoong Pharmaceutical Main Business
Table 87. Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Daewoong Pharmaceutical Latest Developments
Table 89. Livzon Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 90. Livzon Treatment and Prevention of Herpes Labialis Product Offered
Table 91. Livzon Main Business
Table 92. Livzon Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Livzon Latest Developments
Table 94. Luoxin Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 95. Luoxin Treatment and Prevention of Herpes Labialis Product Offered
Table 96. Luoxin Main Business
Table 97. Luoxin Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Luoxin Latest Developments
Table 99. Med shine Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 100. Med shine Treatment and Prevention of Herpes Labialis Product Offered
Table 101. Med shine Main Business
Table 102. Med shine Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Med shine Latest Developments
Table 104. Bayer(Campho Phenique) Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 105. Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Product Offered
Table 106. Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. Bayer(Campho Phenique) Main Business
Table 108. Bayer(Campho Phenique) Latest Developments
Table 109. Blistex Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 110. Blistex Treatment and Prevention of Herpes Labialis Product Offered
Table 111. Blistex Main Business
Table 112. Blistex Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 113. Blistex Latest Developments
Table 114. Kelun Group Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 115. Kelun Group Treatment and Prevention of Herpes Labialis Product Offered
Table 116. Kelun Group Main Business
Table 117. Kelun Group Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. Kelun Group Latest Developments
Table 119. Hikma Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 120. Hikma Treatment and Prevention of Herpes Labialis Product Offered
Table 121. Hikma Main Business
Table 122. Hikma Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 123. Hikma Latest Developments
Table 124. Haiwang Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 125. Haiwang Treatment and Prevention of Herpes Labialis Product Offered
Table 126. Haiwang Main Business
Table 127. Haiwang Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 128. Haiwang Latest Developments
Table 129. Carmex Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 130. Carmex Treatment and Prevention of Herpes Labialis Product Offered
Table 131. Carmex Main Business
Table 132. Carmex Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 133. Carmex Latest Developments
Table 134. Cipher Details, Company Type, Treatment and Prevention of Herpes Labialis Area Served and Its Competitors
Table 135. Cipher Treatment and Prevention of Herpes Labialis Product Offered
Table 136. Cipher Main Business
Table 137. Cipher Treatment and Prevention of Herpes Labialis Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 138. Cipher Latest Developments

LIST OF FIGURES

Figure 1. Treatment and Prevention of Herpes Labialis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Treatment and Prevention of Herpes Labialis Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Treatment and Prevention of Herpes Labialis Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Treatment and Prevention of Herpes Labialis Sales Market Share by Country/Region (2022)
Figure 8. Treatment and Prevention of Herpes Labialis Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Treatment and Prevention of Herpes Labialis Market Size Market Share by Type in 2022
Figure 10. Treatment and Prevention of Herpes Labialis in External Use
Figure 11. Global Treatment and Prevention of Herpes Labialis Market: External Use (2018-2023) & ($ Millions)
Figure 12. Treatment and Prevention of Herpes Labialis in Oral
Figure 13. Global Treatment and Prevention of Herpes Labialis Market: Oral (2018-2023) & ($ Millions)
Figure 14. Treatment and Prevention of Herpes Labialis in Injection
Figure 15. Global Treatment and Prevention of Herpes Labialis Market: Injection (2018-2023) & ($ Millions)
Figure 16. Global Treatment and Prevention of Herpes Labialis Market Size Market Share by Application in 2022
Figure 17. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Player in 2022
Figure 18. Global Treatment and Prevention of Herpes Labialis Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Treatment and Prevention of Herpes Labialis Market Size 2018-2023 ($ Millions)
Figure 20. APAC Treatment and Prevention of Herpes Labialis Market Size 2018-2023 ($ Millions)
Figure 21. Europe Treatment and Prevention of Herpes Labialis Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size 2018-2023 ($ Millions)
Figure 23. Americas Treatment and Prevention of Herpes Labialis Value Market Share by Country in 2022
Figure 24. United States Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Treatment and Prevention of Herpes Labialis Market Size Market Share by Region in 2022
Figure 29. APAC Treatment and Prevention of Herpes Labialis Market Size Market Share by Type in 2022
Figure 30. APAC Treatment and Prevention of Herpes Labialis Market Size Market Share by Application in 2022
Figure 31. China Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Treatment and Prevention of Herpes Labialis Market Size Market Share by Country in 2022
Figure 38. Europe Treatment and Prevention of Herpes Labialis Market Size Market Share by Type (2018-2023)
Figure 39. Europe Treatment and Prevention of Herpes Labialis Market Size Market Share by Application (2018-2023)
Figure 40. Germany Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Treatment and Prevention of Herpes Labialis Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 54. APAC Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 55. Europe Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 57. United States Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 58. Canada Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 61. China Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 62. Japan Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 63. Korea Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 65. India Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 66. Australia Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 67. Germany Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 68. France Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 69. UK Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 70. Italy Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 71. Russia Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 72. Spain Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 75. Israel Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Treatment and Prevention of Herpes Labialis Market Size 2024-2029 ($ Millions)
Figure 78. Global Treatment and Prevention of Herpes Labialis Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Treatment and Prevention of Herpes Labialis Market Size Market Share Forecast by Application (2024-2029)


More Publications